{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:44:05Z","timestamp":1790001845812,"version":"4.0.1"},"reference-count":93,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":300,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alzheimer's &amp;amp; Dementia: Diagnosis, Assessment &amp;amp; Disease Monitoring"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1002\/dad2.12062","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T04:42:42Z","timestamp":1609130562000},"source":"Crossref","is-referenced-by-count":15,"title":["The AT(N) framework for Alzheimer's disease in adults with Down syndrome"],"prefix":"10.1002","volume":"12","author":[{"given":"Michael S.","family":"Rafii","sequence":"first","affiliation":[{"name":"Alzheimer's Therapeutic Research Institute (ATRI) Keck School of Medicine University of Southern California San Diego California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine Neuroscience Washington University School of Medicine in St. Louis St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schupf","sequence":"additional","affiliation":[{"name":"Taub Institute for Research on Alzheimer's Disease and the Aging Brain\/G.H. Sergievsky Center Columbia University Irving Medical Center New York New York USA"},{"name":"Department of Epidemiology Mailman School of Public Health Columbia University New York New York USA"},{"name":"Department of Neurology Neurological Institute of New York, Columbia University Irving Medical Center New York New York USA"},{"name":"Department of Psychiatry Columbia University Medical Center New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Krinsky\u2010McHale","sequence":"additional","affiliation":[{"name":"Department of Psychology NYS Institute for Basic Research in Developmental Disabilities Staten Island New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mapstone","sequence":"additional","affiliation":[{"name":"Department of Neurology University of California Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Silverman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics School of Medicine University of California Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Lott","sequence":"additional","affiliation":[{"name":"Department of Pediatrics School of Medicine University of California Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Klunk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[{"name":"Department of Pathology Gillespie Neuroscience Research Facility, University of California Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Christian","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Psychiatry University of Wisconsin Madison Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Neurology Massachusetts General Hospital Harvard Medical School Charlestown Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Diana","family":"Rosas","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Radiology Massachusetts General Hospital Harvard Medical School Charlestown Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Zaman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry School of Clinical Medicine University of Cambridge Cambridge UK"},{"name":"Cambridgeshire and Peterborough NHS Foundation Trust Fulbourn Hospital Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Strydom","sequence":"additional","affiliation":[{"name":"Department of Forensic and Neurodevelopmental Sciences Institute of Psychiatry, Psychology and Neuroscience King's College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit Department of Neurology Hospital de la Santa Creu i Sant Pau Biomedical Research Institute Sant Pau Universitat Aut\u00f2noma de Barcelona Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Handen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid","family":"O'Bryant","sequence":"additional","affiliation":[{"name":"Institute for Translational Research and Department of Pharmacology and Neuroscience University of North Texas Health Science Center Fort Worth Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.03.002"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002923"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.004"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26151-8"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005476"},{"issue":"2","key":"e_1_2_9_8_1","article-title":"Using the AT(N) framework to examine driving in preclinical AD","volume":"3","author":"Roe CM","year":"2018","journal-title":"Geriatrics (Basel)"},{"key":"e_1_2_9_9_1","unstructured":"Food and Drug Administration.Draft Guidance for Industry. Alzheimer's disease: developing drugs for the treatment of early stage disease.2013.http:\/\/www.fda.gov.libproxy2.usc.edu\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM338287.pdf"},{"key":"e_1_2_9_10_1","unstructured":"Food and Drug Administration.Early Alzheimer's disease: developing drugs for treatment guidance for industry.2018.https:\/\/www-fda-gov.libproxy2.usc.edu\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM596728.pdf"},{"issue":"12","key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/WNL.0000000000003126","article-title":"Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration","volume":"87","author":"Wolz R","year":"2016","journal-title":"Neurology"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70090-0"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170310"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906013202203"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430316"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160836"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1988.tb02018.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1989.tb01232.x"},{"issue":"1","key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis SE","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3983"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-93"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2009.42.1.006"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-017-9341-9"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12074"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12390"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170624"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0598-1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3822"},{"issue":"5","key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-014-0060-7","article-title":"Pro: are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?","volume":"6","author":"Rafii MS.","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0353-4"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.3.303"},{"issue":"1","key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000354370","article-title":"Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature","volume":"3","author":"Ward A","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.10.038"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1352\/2008.113:369-386"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2019.07.017"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32066"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12028"},{"issue":"3","key":"e_1_2_9_38_1","first-page":"179\u2010186","article-title":"Assessment of older people: self\u2010maintaining and instrumental activities of daily living","volume":"9","author":"Lawton MP","year":"1969","journal-title":"Gerontologist"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2014.05.022"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00063-6"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000307"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25456"},{"issue":"17","key":"e_1_2_9_43_1","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High\u2010precision plasma \u03b2\u2010amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler SE","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1352\/1944-7558-125.2.97","article-title":"The search for biomarkers of Alzheimer's disease in down syndrome","volume":"125","author":"Handen BL.","year":"2020","journal-title":"Am J Intellect Dev Disabil"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.10.006"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4228"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.199"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/nmt.15.8"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cortex.2015.07.032"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.04.024"},{"issue":"3","key":"e_1_2_9_51_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/healthcare6030103","article-title":"Signs in people with intellectual disabilities: interviews with managers and staff on the identification process of dementia","volume":"6","author":"Holst G","year":"2018","journal-title":"Healthcare (Basel)"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.571"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.08.009"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205012666150921095724"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu173"},{"issue":"1","key":"e_1_2_9_56_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s11689-019-9300-2","article-title":"Adaptation of the clinical dementia rating scale for adults with Down syndrome","volume":"11","author":"Lessov\u2010Schlaggar CN","year":"2019","journal-title":"J Neurodev Disord"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"issue":"1","key":"e_1_2_9_60_1","first-page":"69","article-title":"A review of biomarkers for Alzheimer's disease in Down syndrome","volume":"6","author":"Lee NC","year":"2017","journal-title":"Neurol Ther"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.09.229"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00239"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2017.05.001"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22713"},{"issue":"10242","key":"e_1_2_9_65_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross\u2010sectional study","volume":"395","author":"Fortea J","year":"2020","journal-title":"Lancet"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170720"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170390"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0730-07.2007"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.05.019"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)01657-3"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(03)00275-1"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.7.979"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.08.007"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fb448b"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.12.030"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-101335"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181aba61e"},{"key":"e_1_2_9_78_1","first-page":"316","article-title":"Blood beta\u2010amyloid and tau in Down syndrome: a comparison with Alzheimer's disease","volume":"8","author":"Lee NC","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22715"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199912)46:6<933::AID-ANA20>3.0.CO;2-4"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-014-8302-1"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30285-0"},{"issue":"6","key":"e_1_2_9_83_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen\u2010year follow\u2010up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology","volume":"51","author":"Margallo\u2010Lana ML","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188802"},{"issue":"1","key":"e_1_2_9_85_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-019-0477-0","article-title":"Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease","volume":"11","author":"Startin CM","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00585"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00191"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2016.02.004"},{"issue":"6","key":"e_1_2_9_89_1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.38.6.938","article-title":"Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology","volume":"38","author":"Schapiro MB","year":"1988","journal-title":"Neurology"},{"issue":"10","key":"e_1_2_9_90_1","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1176\/appi.ajp.160.10.1870","article-title":"Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome","volume":"160","author":"Teipel SJ","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"4","key":"e_1_2_9_91_1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.156.4.564","article-title":"MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia","volume":"156","author":"Aylward EH","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"1","key":"e_1_2_9_92_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1176\/appi.ajp.159.1.74","article-title":"Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease","volume":"159","author":"Krasuski JS","year":"2002","journal-title":"Am J Psychiatry"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0367-x"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190322"}],"container-title":["Alzheimer's &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dad2.12062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/dad2.12062","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dad2.12062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T14:33:54Z","timestamp":1670596434000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dad2.12062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1002\/dad2.12062"],"URL":"https:\/\/doi.org\/10.1002\/dad2.12062","archive":["Portico"],"relation":{},"ISSN":["2352-8729","2352-8729"],"issn-type":[{"value":"2352-8729","type":"print"},{"value":"2352-8729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}